Fluoroscopic image of IdentiTi-LIF Porous Titanium Interbody
Alphatec launched IdentiTi™ implants for lateral interbody fusion procedures, completing commercialization of all of the six IdentiTi systems slated for 2019 release. ATEC also launched the AMP™ Lateral Anti-Migration Plate, and a redesigned, reconfigured version of its Transcend™ PEEK lateral interbody implant.
With the expected launch of SafeOp neuromonitoring next month, the company remains on track with all 12 of its planned commercial launches for 2019.
“Each of these products has been purposefully designed to improve lateral spine surgery by the team that developed and pioneered the lateral approach years ago,” said Pat Miles, Chairman and Chief Executive Officer. “Along with the automated objective information that our SafeOp technology will afford when it launches in November, we are bringing meaningful improvement to lateral surgery outcomes. While we are proud of this year’s accomplishments, we know we are only just beginning to demonstrate the prowess of spine’s new Organic Innovation Machine.”
Alphatec launched IdentiTi™ implants for lateral interbody fusion procedures, completing commercialization of all of the six IdentiTi systems slated for 2019 release. ATEC also launched the AMP™ Lateral Anti-Migration Plate, and a redesigned, reconfigured version of its Transcend™ PEEK lateral interbody implant.
With the expected launch of...
Fluoroscopic image of IdentiTi-LIF Porous Titanium Interbody
Alphatec launched IdentiTi™ implants for lateral interbody fusion procedures, completing commercialization of all of the six IdentiTi systems slated for 2019 release. ATEC also launched the AMP™ Lateral Anti-Migration Plate, and a redesigned, reconfigured version of its Transcend™ PEEK lateral interbody implant.
With the expected launch of SafeOp neuromonitoring next month, the company remains on track with all 12 of its planned commercial launches for 2019.
“Each of these products has been purposefully designed to improve lateral spine surgery by the team that developed and pioneered the lateral approach years ago,” said Pat Miles, Chairman and Chief Executive Officer. “Along with the automated objective information that our SafeOp technology will afford when it launches in November, we are bringing meaningful improvement to lateral surgery outcomes. While we are proud of this year’s accomplishments, we know we are only just beginning to demonstrate the prowess of spine’s new Organic Innovation Machine.”
Copy to clipboard 
